Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Positive results from Allergan's BOTOX Phase III trials on idiopathic overactive bladder

Allergan, Inc. today announced that two Phase III clinical trials of BOTOX (onabotulinumtoxinA) as a potential treatment option for patients with idiopathic overactive bladder met their pre-specified primary endpoints.

29 Mar 2012

Greater out-of-pocket asthma medication costs associated with frequent hospitalizations among children

Greater out-of-pocket asthma medication cost was associated with small reductions in medication use and with more frequent asthma-related hospitalizations among children ages 5 years or older, according to a study in the March 28 issue of JAMA.

28 Mar 2012

Local air pollution may explain neighborhood differences in rates of childhood asthma

Where a child lives can greatly affect his or her risk for asthma. According to a new study by scientists at Columbia University, neighborhood differences in rates of childhood asthma may be explained by varying levels of air pollution from trucks and residential heating oil. Results appear online in the Journal of Exposure Science and Environmental Epidemiology.

28 Mar 2012

Researchers to evaluate new NHS community pharmacy scheme

A new NHS community pharmacy scheme to help patients understand and get the best out of a new medicine is to be tested and evaluated by a team led by The University of Nottingham in collaboration with University College London and Warwick Business School.

28 Mar 2012

Specific precautions must be taken for individuals on longer-term oral glucocorticoid therapy

Millions of people around the world are prescribed glucocorticoids for a wide variety of inflammatory conditions, including, rheumatoid arthritis, asthma and inflammatory bowel diseases. Although they are effective and widely used, one of the potentially serious side effects of these medications is glucocorticoid-induced osteoporosis.

28 Mar 2012

Top-line results from two Targacept TC-6987 Phase 2 studies on asthma, type 2 diabetes

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced top-line results from two separate exploratory Phase 2 studies of its product candidate TC-6987 conducted in the United States, one in asthma and one in type 2 diabetes.

28 Mar 2012

First study to explore differential gender effects of secondhand smoke exposure

The negative health effects of early-life exposure to secondhand smoke appear to impact girls more than boys-particularly those with early-life allergic sensitization, according to new research from the University of Cincinnati (UC) College of Medicine.

27 Mar 2012

FDA approves Teva's QNASL nasal aerosol corticosteroid

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QNASL Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.

26 Mar 2012

Commensal bacteria may play an important role in influencing and controlling allergic inflammation

When poet Walt Whitman wrote that we "contain multitudes," he was speaking metaphorically, but he was correct in the literal sense. Every human being carries over 100 trillion individual bacterial cells within the intestine -- ten times more cells than comprise the body itself.

26 Mar 2012

Hi-tech 3D imaging may improve lives of chronic lung disease patients

Pioneering research in Southampton, using hi-tech 3D imaging, could improve the lives of those suffering from chronic lung disease.

26 Mar 2012

Allergy season comes early with high pollen counts

After the end of an unusually warm winter the spring has come early and this has affected asthmatics in parts of the South and Midwest this year. The 25 to 35 percent of people who suffer from hay fever, the early arrival of warm weather meant an unusually early start to allergy season due to the abundance of pollens.

25 Mar 2012

$Bronchoscopy helps distinguish phenotypes, personalize therapy for refractory asthma$

Bronchoscopy helps distinguish phenotypes, personalize therapy for refractory asthma

Using a bronchoscope to visually examine the airways and collect fluid and tissue can help guide effective therapy for difficult-to-treat asthma patients, according to researchers at National Jewish Health.

23 Mar 2012

Investigators identify proteins that may indicate fetus at risk for UTI-induced prematurity

Investigators in The Research Institute at Nationwide Children's Hospital have developed a mouse model in which a mother's urinary tract infection negatively affects the offspring, an occurrence anecdotally observed in humans. Using this first-of-its-kind model, they have identified proteins in the blood that may indicate whether such an infection might stunt fetal growth.

23 Mar 2012

Women with low serum adiponectin levels more likely to develop asthma

Low serum adiponectin levels predict an increased future risk for developing asthma in middle-aged women, particularly among smokers, according to a new study.

23 Mar 2012

State roundup: Oregon's coordinated care program moves ahead

Ten thousand more employees at five city agencies have signed on to Mayor Rahm Emanuel's plan to raise monthly health insurance premiums by $50 for employees who fail to participate in a "wellness program" to manage chronic health problems. Emanuel hopes to save $20 million in 2012 -- and $240 million over four years -- by riding herd over costly, but controllable problems like diabetes, high blood pressure, heart disease and asthma.

22 Mar 2012

Urban children more likely to be smokers

More than 75 percent of fourth-graders in urban and rural settings have measurable levels of a nicotine breakdown product in their saliva that documents their second-hand smoke exposure, researchers report.

22 Mar 2012

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

21 Mar 2012

Pediatricians' unconscious racial bias may affect pain medication decisions

Pediatricians who show an unconscious preference for European Americans tend to prescribe better pain-management for white patients than they do for African-American patients, new University of Washington research shows.

20 Mar 2012

AAFA releases new 'Spring Allergy Capital' rankings

Today is the vernal equinox – otherwise known as the official end of winter and the start of spring. But even if you didn't look at your calendar today, chances are your nose already figured it out. That's because more than 40 million Americans have nasal allergies.

20 Mar 2012

Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment

Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.

20 Mar 2012

Asthma News and Research

Further Reading

Positive results from Allergan's BOTOX Phase III trials on idiopathic overactive bladder

Greater out-of-pocket asthma medication costs associated with frequent hospitalizations among children

Local air pollution may explain neighborhood differences in rates of childhood asthma

Researchers to evaluate new NHS community pharmacy scheme

Specific precautions must be taken for individuals on longer-term oral glucocorticoid therapy

Top-line results from two Targacept TC-6987 Phase 2 studies on asthma, type 2 diabetes

First study to explore differential gender effects of secondhand smoke exposure

FDA approves Teva's QNASL nasal aerosol corticosteroid

Commensal bacteria may play an important role in influencing and controlling allergic inflammation

Hi-tech 3D imaging may improve lives of chronic lung disease patients

Allergy season comes early with high pollen counts

Bronchoscopy helps distinguish phenotypes, personalize therapy for refractory asthma

Investigators identify proteins that may indicate fetus at risk for UTI-induced prematurity

Women with low serum adiponectin levels more likely to develop asthma

State roundup: Oregon's coordinated care program moves ahead

Urban children more likely to be smokers

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Pediatricians' unconscious racial bias may affect pain medication decisions

AAFA releases new 'Spring Allergy Capital' rankings

Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News